March 2015

The Board of Directors of the National Legislative Association on Prescription Drug Prices (NLARx) has voted to dissolve. The…

 Today, the Centers for Medicare and Medicaid Services (CMS) released five new operational FAQs that can help stakeholders working…

On Tuesday, March 10, 2015 1:30 p.m. – 2:30 p.m. (EST), the Centers for Medicare and Medicaid Services is hosting a live Question…

The Anti-Kickback statute forbids a doctor from receiving payment in return for making referrals. A recent Seventh…

Today, the Food and Drug Administration approved Zarxio (filgrastim-sndz), the first biosimilar product approved in the U.S. …

Are the patient outcomes of newly trained surgeons comparable to the outcomes of experienced surgeons performing the…

CBI’s Pharmaceutical Compliance Congress had an impressive array of presenters this year. The government speakers were all…

At yesterday's session of CBI's Pharmaceutical Compliance Conference in Washington, DC, Andrew Ceresney, Director of Enforcement…

Pharmaceutical and device manufacturers operating in France must brace for more extensive reporting requirements under…

Last week, in our Vermont transparency update, we wrote that Vermont’s Attorney General enforced the state’s Prescribed…